Surgical tracheotomy performed with and without dual antiplatelet therapy

• Authors: Andrej Markota , Andreja Sinkovič , Bogdan Čizmarević
• Languages of publication: EN

Abstracts

EN

Some patients who need dual antiplatelet
therapy sometimes require tracheotomy. Aim of this study
was to compare the rate of complications during and
after surgical tracheotomy between patients requiring
dual antiplatelet therapy and those without dual antiplatelet
therapy. We retrospectively included 79 patients
(62% men, mean age 64 ± 14 years) in the period 2007-
2011. The following complications were analyzed: need
for surgical revision within 24 hours after tracheotomy,
need for bronchoscopy within 24 hour after tracheotomy,
need for blood transfusion within 24 hours after tracheotomy,
death attributed to tracheotomy and any complication
attributed to tracheotomy. We compared patients
where tracheotomy was performed while receiving dual
antiplatelet therapy (n=27, 34%) to patients where tracheotomy
was performed without dual antiplatelet therapy
(n=52, 66%). Nonsignificant differences between the two
groups were observed general characteristics. There were
no statistically significant differences in complications
after tracheotomy (surgical revision after tracheotomy
p=0.63, bronchoscopy after tracheotomy p=0.74, blood
transfusion after tracheotomy p=0.59, death attributed to
tracheotomy p=1.00 and any complication attributed to
tracheotomy p=1.00). The study shows that tracheotomy
is safe in cardiac patients on dual antiplatelet therapy.

Keywords

EN

Tracheotomy; complications; antiplatelettherapy; bleeding; intensive care unit

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2014
• Volume: 10
• Issue: 1

Dates

accepted

26 - 9 - 2014

online

29 - 12 - 2014

received

31 - 10 - 2013

Contributors

author

Andrej Markota

• Medical Intensive Care
  Unit, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  Slovenia

author

Andreja Sinkovič

• Medical Intensive Care
  Unit, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  Slovenia

author

Bogdan Čizmarević

• Ear, Nose and Throat Diseases Department,
  University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  Slovenia

References

• [1] Hsu C.L., Chen K.Y., Chang C.H., Jerng J.S., Yu C.J., Yang P.C.,Timing of tracheostomy as a determinant of weaning successin critically ill patients: a retrospective study, Crit. Care., 2005;9: R46-5
• [2] Heffner J.E., Miller K.S., Sahn S.A., Tracheostomy inthe intensive care unit. Part 1: Indications, technique,management, Chest, 1986; 90: 269-274
• [3] Combes A., Luyt C.E., Nieszkowska A., Trouillet J.L., Gibert C.,Chastre J., Is tracheostomy associated with better outcomes forpatients requiring long-term mechanical ventilation?, Crit. Care.Med., 2007; 35: 802-807[WoS]
• [4] Heffner J.E., Medical indications for tracheotomy, Chest, 1989;96: 186-190
• [5] Upadhyay A., Maurer J., Turner J., Tiszenkel H., Rosengart T.,Elective bedside tracheostomy in the intensive care unit, J. Am.Coll. Surg., 1996; 183: 51-55
• [6] Korte W., Cattaneo M., Chassot P.G., Eichinger S., vonHeymann C., Hofmann N. et al., Peri-operative management ofantiplatelet therapy in patients with coronary artery disease:joint position paper by members of the working group onPerioperative Haemostasis of the Society on Thrombosisand Haemostasis Research (GTH), the working group onPerioperative Coagulation of the Austrian Society for Anesthesiology,Resuscitation and Intensive Care (ÖGARI) and theWorking Group Thrombosis of the European Society forCardiology (ESC), Thromb. Haemost., 2011; 105: 743-749, doi:10.1160/TH10-04-0217[Crossref]
• [7] Fitchett D., Eikelboom J., Fremes S., Mazer D., Singh S., BittiraB. et al., Dual antiplatelet therapy in patients requiring urgentcoronary artery bypass grafting surgery: a position statementof the Canadian Cardiovascular Society, Can. J. Cardiol., 2009;25: 683-689[WoS]
• [8] Voigt I., Naber C., Bleeding complications of percutaneousdilatation tracheostomy (PDT) in a group of ICU patients withdual antiplatelet therapy, Crit. Care. Shock, 2012; 15: 70-76
• [9] Sharma S.C., Singh V.K., Anand A., Rao B.K., Percutaneoustracheostomy in patients with coagulopathy, In: J.D. Chiche(Ed.), Abstract of the 23rd ESICM Annual Congress, 2010: 163
• [10] Beiderlinden M., Eikermann M., Lehmann N., Adamzik M.,Peters J., Risk factors associated with bleeding during and afterpercutaneous dilational tracheostomy, Anaesthesia, 2007; 62:342-346[WoS]
• [11] Kluge S., Meyer A., Kühnelt P., Baumann H.J., Kreymann G.,Percutaneous tracheostomy is safe in patients with severethrombocytopenia, Chest, 2004; 126: 547-551
• [12] Auzinger G., O’Callaghan G.P., Bernal W., Sizer E., WendonJ.A., Percutaneous Tracheostomy in patients with severe liverdisease and a high incidence of refractory coagulopathy: aprospective trial, Crit. Care., 2007; 11: R110[WoS][Crossref]
• [13] Blankenship D.R., Kulbersh B.D., Gourin C.G., Blanchard A.R.,Terris D.J., High-risk tracheostomy: exploring the limits of thepercutaneous tracheostomy, Laryngoscope, 2005; 115: 987-989
• [14] Blot F., Nitenberg G., Guiguet M., Casetta M., Antoun S., PicoJ.L. et al., Safety of tracheotomy in neutropenic patients: aretrospective study of 26 consecutive cases, Intensive CareMed, 1995; 21: 687-690
• [15] Rayess H.M., Revenaugh P.C., Benninger M.S., Knott P.D.,Predictive factors for patient outcomes following open bedsidetracheotomy, Laryngoscope, 2013; 123: 923-928, doi: 10.1002/lary.23887[WoS][Crossref]

Identifiers

DOI

10.1515/med-2015-0018